|
|
- 2019
The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibilityDOI: 10.20892/j.issn.2095-3941.2018.0253 Keywords: GSK-3β, NK cells, NKG2D/NKG2DLs, ROS, eIF2B, breast cancer Abstract: To examine the effect of pSer9-GSK-3β on breast cancer and to determine whether the underlying metabolic and immunological mechanism is associated with ROS/eIF2B and natural killer (NK) cells
|
